Indian venture capital firm Blume Ventures has reached a first close of $40 million on Blume Ventures Fund III, its third early-stage fund.
Blume aims to close Fund III by the end of the year, with a target of $80 million. The commitments received so far include both current LPs and new anchor investors from the US, India, Japan, and other...
Motilal Oswal Private Equity (MOPE) and healthcare-focused GP Invascent Capital have invested in Indian pharmaceutical developer Symbiotec Pharmalab, providing an exit for Actis Capital.
The transformation of Manuka Health from loosely run family affair into professional segment leader helped organize a cottage industry into big business
A selection of the key fundraising, investment and exit events - presented in chronological order - from the past 12 months
Fuyoukache, a Chinese online truck logistics platform, has raised $170 million in a Series D round led by a Bank of China investment unit and Matrix Partners China. Prospect Avenue Capital also participated.